
Everything You Need To Know About the FDA’s Draft Guidance on Remote Interactive Evaluations
In October 2023, the FDA issued draft guidance on Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities. The document explains how the FDA




